Cell-Type Heterogeneity in DNA Methylation Studies: Statistical Methods and Guidelines
Epigenetic Epidemiology: Second Edition, Page: 67-96
2022
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Studies in epigenetic epidemiology have reported increasing numbers of epigenetic biomarkers associated with a wide range of exposures and outcomes. Due to cost and technical difficulties, these markers are usually derived from complex tissues that are composed of many different cell-types. This cell-type heterogeneity prevents the identification of cell-type specific epigenetic alterations, posing significant challenges to the interpretation and understanding of these markers. Consequently, there is a strong need to develop cost-effective computational solutions to tackle the cell-type heterogeneity problem. Here, I discuss some recently proposed cell-type deconvolution algorithms aimed at estimating cell-type fractions and identifying cell-type specific differential DNA methylation changes. I describe their successful application to epigenome studies. We also discuss their main limitations, providing general guidelines for their successful implementation and for correctly interpretating results derived from them.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85159026422&origin=inward; http://dx.doi.org/10.1007/978-3-030-94475-9_4; https://link.springer.com/10.1007/978-3-030-94475-9_4; https://dx.doi.org/10.1007/978-3-030-94475-9_4; https://link.springer.com/chapter/10.1007/978-3-030-94475-9_4
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know